News News November, 2020 IGM Biosciences to Present First Clinical Data from IGM-2323 in Non-Hodgkin’s Lymphoma at 2020 ASH Annual Meeting Read More... September, 2020 IGM Biosciences Initiates First-in-Human Clinical Trial of IGM-8444 for the Treatment of Solid Cancers and Non-Hodgkin’s Lymphoma Read More... September, 2020 AbCellera and IGM Biosciences Announce Multi-Year Antibody Discovery Collaboration Read More... September, 2020 IGM Biosciences to Present at Four Upcoming Investor Conferences Read More... August, 2020 IGM Biosciences Announces Second Quarter 2020 Financial Results and Provides Corporate Update Read More... August, 2020 IGM Biosciences to Present at the 2020 Wedbush PacGrow Healthcare Virtual Conference Read More... May, 2020 IGM Biosciences to Present at the Jefferies 2020 Healthcare Conference Read More... May, 2020 IGM Biosciences to Present at the 2020 RBC Capital Markets Global Healthcare Conference Read More... May, 2020 IGM Biosciences Announces First Quarter 2020 Financial Results and Provides Corporate Update Read More... April, 2020 Atreca, BeiGene, and IGM Biosciences Agree to Collaborate on Novel Antibody Treatment for COVID-19 Read More... « Previous 1 2 3 4 Next »
